Pharmacy Medical News about Antipsychotics

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09

Breden EL et al. – The article discusses the risk of weight gain, hyperglycemia, hyperlipidemia, hyperprolactinemia, and cardiovascular concerns associated with second–generation antipsychotic agents. It also discusses the proposed mechanisms for each of these adverse effects.

<< Previous
A Practical Approach for Training Pharmacists and Pharmacy...

Next >>
Sibutramine for weight gain attenuation during smoking cessation...

First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies
British Journal of Psychiatry, 11/12/09 Relevance Score: 88%

Maternal schizophrenia and pregnancy outcome: Does the use of antipsychotics make a difference
Schizophrenia Research, 11/12/09 Relevance Score: 87%

Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients
European Psychiatry, 11/06/09 Relevance Score: 87%

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09 Relevance Score: 87%

Antipsychotic effects on auditory sensory gating in schizophrenia patients
European Neuropsychopharmacology, 10/21/09 Relevance Score: 87%